Wise Group's Regulatory Classification Gap — What the Bank Charter Denial Actually Means

Wise Group listed on the Nasdaq on May 11, 2026. About six weeks later, it turned out the company had already been caught failing at anti-money-laundering controls under one regulatory regime — and regulators were going to let that record block it from upgrading to a higher one. The stock dropped as much as 20% on the first shock, then hit again when a federal banking regulator formally said no. Now a securities class action is winding through the courts, alleging that Wise told the market everything was fine while the plumbing said otherwise.

The lawsuit is the noise. The structural story is the classification gap between what Wise is and what it wanted to become.

The category boundary that tripped everything up

Wise operates today as a money services business — what the regulations call an MSB. MSBs move money but don't hold a bank charter. They face a set of anti-money-laundering (AML) rules. Not trivial rules, but a specific, well-defined tier.

In June 2025, Wise applied to the OCC for a national trust bank charter, proposing to set up "Wise National Trust" in Austin, Texas. A bank charter is a higher tier. It comes with Federal Reserve master account access, fiduciary powers, and the ability to operate inside the U.S. banking system rather than just alongside it. It also comes with strictly higher AML/CFT (anti-money-laundering, countering the financing of terrorism) requirements.

Here is the thing that makes the story click into place: Wise had not finished cleaning up the AML problems at the MSB level before asking to graduate to the bank level.

In July 2025, a coalition of six U.S. state regulators found that Wise US had failed to file suspicious activity reports on time, had transaction monitoring data that was unreliable enough to require a lookback on previously closed accounts, and had not performed independent AML program reviews at the required frequency. Wise paid $4.2 million and agreed to hire an independent third party to verify corrective actions and submit quarterly progress reports for two years — through 2027.

Then Wise applied for a bank charter. The OCC said, in effect: you haven't met the rules at your current level, and the bank level demands even more. The July 2026 denial letter from OCC senior deputy comptroller Stephen Lybarger cited "significant supervisory and compliance concerns," noting that Wise US had a "record of compliance failure with money services business requirements" and did not demonstrate "sufficient familiarity with federal banking laws". The OCC also flagged inadequate management — the proposed directors and executives lacked fiduciary experience, and the proposed CEO had already left the company.

The legal interface is the mechanism. A bank charter is not just a prestige upgrade. It is a different regulatory bucket with its own AML bar, its own governance requirements, and its own supervisory intensity. You can't say "we're investing in compliance" and simultaneously ask for a license that demands proven compliance competence. The OCC read the remediation clock — two years of quarterly reporting with an independent reviewer — and determined that until those reports came clean, Wise couldn't be trusted with the higher tier.

That is the structure. Everything else follows from it.

The shocks in sequence

The market didn't get one piece of bad news. It got two, spaced about six weeks apart, each revealing a deeper layer.

On June 1, Reuters reported that Belgian prosecutors were investigating Wise Europe over roughly €500 million in suspicious transactions potentially linked to fraud, drug trafficking, and corruption. The investigation had apparently been going on for months. Shares fell as much as 20% in early morning trading. Wise called the inquiries "routine" and said they were not indicative of non-compliance — which is the standard response, and also the response that the class action says was misleading.

Then on July 24, a Wall Street Journal article reported that the OCC had denied Wise's trust bank charter application. The article came out the day after the OCC's formal decision on July 21. Shares fell another 6%.

The class action, filed as Daugherty v. Wise Group plc in the Southern District of New York, covers the period from May 11 through July 23 — from the Nasdaq listing through the day before the OCC denial became public. The complaint alleges that Wise made materially false or misleading statements about its AML compliance, understated the Belgian investigation, and gave investors no reason to believe the OCC would deny the charter. The defendants include Wise itself, CEO Kristo Käärmann, and CFO Emmanuel Thomassin.

A securities class action of this type is not itself a finding of fraud. It is an allegation that the company's public statements did not match its internal reality. The lead plaintiff deadline is September 28. The case will likely face a motion to dismiss, and the real question will be whether the company's disclosures — in its registration statement, earnings calls, and regulatory filings — were enough to cover the ground the complaint says they missed.

The lawsuit is a consequence of the stock drops. It is not the reason the stock dropped.

What the business is doing beneath the regulatory noise

Here is where the story splits into two separate threads. One is the regulatory structure — the classification gap, the remediation clock, the Belgian probe. The other is the operating business, which is growing fast.

Wise's fiscal year ended March 31, 2026. The full-year results, reported June 25, show a company scaling through the same period its AML problems were being exposed:

• Net revenue was $2.5 billion, up 19% year over year.
• Income before tax was $660 million — a 26% margin, above the company's own guided range of 20-25%.
• Cross-border volume reached $243 billion, up 31%.
• 19 million active customers, up 21%.
• Customer holdings in Wise accounts grew 40% to $39 billion.
• About half of revenue now comes from non-cross-border sources — card fees, interest income on customer balances, and other services.

For FY2027, Wise guided for mid-range revenue growth within its 15-20% target band and income before tax margins at the top of the 20-25% range. The company also announced a new $500 million share repurchase program.

The business machine is working. The regulatory machine is not. They are not the same machine, but they are attached to the same company, and the market has to price both.

The stock currently trades around $12.78, down about 20% from its 52-week high of $17.47 and up from the lows around $10.72 hit in early June. The valuation numbers — roughly 31.5 times trailing earnings, about 6.3 times trailing revenue — sit somewhere between growth premium and regulatory discount. That is not a precise reading. It is the market's current compromise between two contradictory facts.

What an investor is actually buying

Let me lay out the two claims and the gap between them.

The bull claim: Wise is a high-margin, fast-growing payments network with a genuine cost advantage and a growing customer base that is shifting from one-time transfers to ongoing account holdings. The AML issues are a compliance investment problem, not a business model problem. The company is already remediation-bound through 2027, with one-third of its workforce reportedly focused on financial crime prevention. The OCC denial was a setback, not a death sentence — Wise has said it will reapply, potentially under the new GENIUS Act framework that creates a regulated path for stablecoin-related banking activities.

The bear claim: The AML problems are structural, not seasonal. A company that can't file suspicious activity reports on time and can't maintain reliable transaction monitoring data at the MSB level is facing a fundamentally harder problem at the bank level. The Belgian investigation — €500 million in suspicious transactions, potentially involving drug trafficking and corruption — is not a one-off; it is a signal that the company's controls did not catch what should have been caught. Until remediation is verified and the Belgian probe resolves, any reapplication for a bank charter is speculation. And without a U.S. bank charter, Wise's growth in its largest market opportunity remains constrained.

Both claims use the same evidence. The question is which side of the evidence you weight.

The regulatory remediation runs through 2027 with quarterly reporting and independent verification. That is a known timeline. The Belgian investigation has no public timeline — it could resolve as a routine matter, or it could produce charges or fines. The OCC denial can be revisited once remediation is complete, but there is no assurance of approval.

The operating numbers through FY2026 are real. Revenue growth, margin expansion, customer count, and volume growth are not contingent on a bank charter. What a charter would add is deeper U.S. integration, Fed master account access, and the optionality to expand into stablecoins and fiduciary services. What it would also bring is more intensive supervision. The trade is not clean in either direction.

One way to think about the investment: you are buying a growing payments business with an unresolved compliance overhang. The overhang has a known U.S. remediation deadline (2027), an unknown European probe outcome, and a denied-but-reopenable U.S. charter path. The operating business continues to compound. The regulatory machine is running its own clock. Whether those two clocks eventually sync is the live question — and nobody knows the answer yet.